Comprehensive Swallowing Rehabilitation in Patients With MSA
Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy: A Randomized Controlled Trial
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this study is to investigate the effect of comprehensive swallowing rehabilitation in patients with multiple system atrophy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedStudy Start
First participant enrolled
May 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 27, 2026
April 1, 2026
6.5 years
March 1, 2021
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Penetration-Aspiration Scale
at 6 weeks
Videofluoroscopic dysphagia scale
at 6 weeks
Secondary Outcomes (10)
Penetration-Aspiration Scale
at 12 weeks
Videofluoroscopic dysphagia scale
at 12 weeks
Peak Cough Flow
at 6 weeks, at 12 weeks
Maximal Inspiratory Pressure
at 6 weeks, at 12 weeks
Maximal Expiratory Pressure
at 6 weeks, at 12 weeks
- +5 more secondary outcomes
Study Arms (2)
Comprehensive swallowing rehabilitation
EXPERIMENTALSwallowing education
ACTIVE COMPARATORInterventions
The treatment time per session is 30 minutes. Total 12 sessions are provided for 6 weeks.
The education is 30 minutes. Total 1 session is provided immediately after baseline evaluation.
Eligibility Criteria
You may qualify if:
- Age \>19 years
- Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria
- Clinically diagnosed to have dysphagia by a physiatrist
- Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months
You may not qualify if:
- Moderate to severe cognitive dysfunction with Mini-mental State Examination score \< 19
- Comorbidities or structural abnormalities that may affect swallowing function
- Other comorbidities that make it difficult to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Han Gil Seo, MD, PhD
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 1, 2021
First Posted
March 4, 2021
Study Start
May 17, 2021
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 27, 2026
Record last verified: 2026-04